tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 168 are a BUY (69.14%), 56 are a HOLD (23.05%), 19 are a SELL (7.82%).
Analyst Andrew Berens, carries an average stock price target met ratio of 58.07% that have a potential upside of 33.69% achieved within 237 days. Previously, Andrew Berens worked at LEERINK.
Andrew Berens’s has documented 479 price targets and ratings displayed on 39 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on AGIO, Agios Pharm at 21-Nov-2025.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$51
5 days ago
(24-Nov-2025)
1/1 (100%)
$9.18 (21.95%)
27
Buy
$32
$2.8 (9.59%)
$28
5 days ago
(24-Nov-2025)
6/8 (75%)
$-13.49 (-29.65%)
70
Hold
$34
$4.8 (16.44%)
$40
8 days ago
(21-Nov-2025)
12/15 (80%)
$-11.49 (-25.26%)
187
Buy
$48
$18.8 (64.38%)
$56
8 days ago
(21-Nov-2025)
0/4 (0%)
$2.51 (5.52%)
Hold
$20
$-9.2 (-31.51%)
$43
8 days ago
(21-Nov-2025)
5/6 (83.33%)
$-25.49 (-56.03%)
181
Which stock is Andrew Berens is most bullish on?
Which stock is Andrew Berens is most reserved on?
What Year was the first public recommendation made by Andrew Berens?
